Sign in or Register   Sign in or Register
  |  

Mouse Anti-CD226 Recombinant Antibody (CBYCD-128) (CBMAB-D0068-YC)

Provided herein is a Mouse monoclonal antibody, which binds to CD226 Molecule (CD226). The antibody can be used for immunoassay techniques, such as WB, ICC, IHC-P, IHC-Fr, ELISA.
See all CD226 antibodies

Summary

Host Animal
Mouse
Specificity
Human
Clone
CBYCD-128
Antibody Isotype
IgG
Application
WB, ICC, IHC-P, IHC-Fr, ELISA

Basic Information

Specificity
Human
Antibody Isotype
IgG
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Storage
Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

Full Name
CD226 Molecule
Introduction
CD226 (CD226 Molecule) is a protein coding gene. Diseases associated with CD226 include Ovarian Cystic Teratoma and Mature Teratoma Of The Ovary. Among its related pathways are Hematopoietic Stem Cell Differentiation Pathways and Lineage-specific Markers and Innate Immune System.
Entrez Gene ID
10666
UniProt ID
Q15762
Alternative Names
CD226 Molecule; CD226 Antigen; DNAM-1; DNAM1; T Lineage-Specific Activation Antigen 1 Antigen; Platelet And T Cell Activation Antigen 1;
Function
Involved in intercellular adhesion, lymphocyte signaling, cytotoxicity and lymphokine secretion mediated by cytotoxic T-lymphocyte (CTL) and NK cell (PubMed:8673704).
Cell surface receptor for NECTIN2. Upon ligand binding, stimulates T-cell proliferation and cytokine production, including that of IL2, IL5, IL10, IL13, and IFNG. Competes with PVRIG for NECTIN2-binding (PubMed:26755705).
Biological Process
Cell adhesion Source: ProtInc
Cell recognition Source: BHF-UCL
Positive regulation of Fc receptor mediated stimulatory signaling pathway Source: BHF-UCL
Positive regulation of immunoglobulin mediated immune response Source: BHF-UCL
Positive regulation of interferon-gamma production Source: GO_Central
Positive regulation of mast cell activation Source: BHF-UCL
Positive regulation of natural killer cell cytokine production Source: GO_Central
Positive regulation of natural killer cell mediated cytotoxicity Source: BHF-UCL
Positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target Source: BHF-UCL
Positive regulation of T cell receptor signaling pathway Source: UniProtKB
Regulation of immune response Source: Reactome
Signal transduction Source: ProtInc
Cellular Location
Cell membrane
Topology
Extracellular: 19-254
Helical: 255-275
Cytoplasmic: 276-336

Bi, J. (2021). CD226: a potent driver of antitumor immunity that needs to be maintained. Cellular & Molecular Immunology, 1-2.

Feng, M., Wu, Z., Zhou, Y., Wei, Z., Tian, E., Mei, S., ... & Zhu, D. (2021). BCL9 regulates CD226 and CD96 checkpoints in CD8+ T cells to improve PD-1 response in cancer. Signal transduction and targeted therapy, 6(1), 1-14.

Huang, Z., Qi, G., Miller, J. S., & Zheng, S. G. (2020). CD226: An emerging role in immunologic diseases. Frontiers in cell and developmental biology, 8, 564.

Wang, N., Yi, H., Fang, L., Jin, J., Ma, Q., Shen, Y., ... & Chen, L. (2020). CD226 attenuates Treg proliferation via Akt and Erk signaling in an EAE model. Frontiers in immunology, 11, 1883.

Shapiro, M. R., Yeh, W. I., Longfield, J. R., Gallagher, J., Infante, C. M., Wellford, S., ... & Brusko, T. M. (2020). CD226 deletion reduces Type 1 diabetes in the NOD mouse by impairing thymocyte development and peripheral T cell activation. Frontiers in immunology, 11, 2180.

Weulersse, M., Asrir, A., Pichler, A. C., Lemaitre, L., Braun, M., Carrié, N., ... & Martinet, L. (2020). Eomes-dependent loss of the co-activating receptor CD226 restrains CD8+ T cell anti-tumor functions and limits the efficacy of cancer immunotherapy. Immunity, 53(4), 824-839.

Wang, H., Qi, J., Zhang, S., Li, Y., Tan, S., & Gao, G. F. (2019). Binding mode of the side-by-side two-IgV molecule CD226/DNAM-1 to its ligand CD155/Necl-5. Proceedings of the National Academy of Sciences, 116(3), 988-996.

Wang, N., Liang, S., Jin, J., Fang, L., Ma, Q., Wang, X., ... & Chen, L. (2019). CD226 attenuates Treg suppressive capacity via CTLA-4 and TIGIT during EAE. Immunologic research, 67(6), 486-496.

Fourcade, J., Sun, Z., Chauvin, J. M., Ka, M., Davar, D., Pagliano, O., ... & Zarour, H. M. (2018). CD226 opposes TIGIT to disrupt Tregs in melanoma. JCI insight, 3(14).

Wagner, A. K., Kadri, N., Snäll, J., Brodin, P., Gilfillan, S., Colonna, M., ... & Chambers, B. J. (2017). Expression of CD226 is associated to but not required for NK cell education. Nature communications, 8(1), 1-14.

Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-CD226 Recombinant Antibody (CBYCD-128)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare